2003
DOI: 10.1097/01.sla.0000090473.63393.e9
|View full text |Cite
|
Sign up to set email alerts
|

Endovascular Stent Graft Repair of Abdominal and Thoracic Aortic Aneurysms

Abstract: Stent graft therapy for aortic aneurysms is a valuable alternative to open aortic repair, especially in older sicker patients with large aneurysms. Continued device improvements coupled with an enhanced understanding of the important role of aortic pathology in determining therapeutic success will eventually permit ESGs to be a more durable treatment of aortic aneurysms.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
10
0

Year Published

2005
2005
2013
2013

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 56 publications
(10 citation statements)
references
References 57 publications
0
10
0
Order By: Relevance
“…Amid the surge in development of endovascular stent grafts for thoracic aortic disease, there has been a bias in favor of endovascular treatments that has been thwarted by inappropriate comparisons of the results of open thoracoabdominal aortic replacements (ie, more extensive resections) to thoracic endovascular aortic repair (TEVAR) of more limited descending thoracic aortic aneurysms. The feasibility of TEVAR for descending thoracic aortic aneurysms is now firmly established, 26,27,45,57,[65][66][67][68][69]71,[107][108][109][110][111][112][113][114][115][116][117][118][119][120][121][122][123] but the indications for doing so have not been clearly defined. In part, the discrepancy between feasibility and indication rests with the lack of long-term followup data in favor of TEVAR and, consequently, a lack of understanding of the relative risk of TEVAR compared with medical management and conventional open replacement of descending thoracic aortic aneurysms.…”
Section: Resultsmentioning
confidence: 99%
“…Amid the surge in development of endovascular stent grafts for thoracic aortic disease, there has been a bias in favor of endovascular treatments that has been thwarted by inappropriate comparisons of the results of open thoracoabdominal aortic replacements (ie, more extensive resections) to thoracic endovascular aortic repair (TEVAR) of more limited descending thoracic aortic aneurysms. The feasibility of TEVAR for descending thoracic aortic aneurysms is now firmly established, 26,27,45,57,[65][66][67][68][69]71,[107][108][109][110][111][112][113][114][115][116][117][118][119][120][121][122][123] but the indications for doing so have not been clearly defined. In part, the discrepancy between feasibility and indication rests with the lack of long-term followup data in favor of TEVAR and, consequently, a lack of understanding of the relative risk of TEVAR compared with medical management and conventional open replacement of descending thoracic aortic aneurysms.…”
Section: Resultsmentioning
confidence: 99%
“…In recent series, mid-term results are promising without operative mortality (9-10) and a technical success rate of 85-100% (8)(9)(10).…”
Section: Discussionmentioning
confidence: 95%
“…Discussion remains with regard to the incidence, the clinical approach and management of some endoleaks (8)(9)(10). The reported incidence of early type II endoleaks is 10-14% (8,9) and of type I and III endoleaks is 11-15% (8,10). Consensus exists on the uniform dangers of untreated type I endoleaks (8).…”
Section: Discussionmentioning
confidence: 98%
See 2 more Smart Citations